E. Rolland Dickson
#159,949
Most Influential Person Now
E. Rolland Dickson's AcademicInfluence.com Rankings
E. Rolland Dicksonmathematics Degrees
Mathematics
#7321
World Rank
#9971
Historical Rank
Statistics
#825
World Rank
#915
Historical Rank

E. Rolland Dicksonphilosophy Degrees
Philosophy
#9197
World Rank
#12719
Historical Rank
Logic
#6186
World Rank
#7675
Historical Rank

Download Badge
Mathematics Philosophy
E. Rolland Dickson's Degrees
- PhD Biostatistics University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is E. Rolland Dickson Influential?
(Suggest an Edit or Addition)E. Rolland Dickson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A model to predict survival in patients with end‐stage liver disease (2001) (2667)
- A model to predict survival in patients with end-stage liver disease. (2001) (1889)
- Prognosis in primary biliary cirrhosis: Model for decision making (1989) (798)
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. (1997) (597)
- Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis (1989) (588)
- Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) (1978) (494)
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. (1994) (438)
- Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. (2003) (407)
- A revised natural history model for primary sclerosing cholangitis. (1997) (349)
- Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis (1991) (299)
- Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. (1993) (288)
- Epidemiology and natural history of primary biliary cirrhosis in a U.S. community (2000) (286)
- Primary sclerosing cholangitis: refinement and validation of survival models. (1992) (248)
- Autoimmune associations in primary biliary cirrhosis. (1982) (248)
- Bone loss and reduced osteoblast function in primary biliary cirrhosis. (1985) (226)
- Primary biliary cirrhosis: Prediction of short‐term survival based on repeated patient visits (1994) (221)
- Efficacy of liver transplantation in patients with primary biliary cirrhosis. (1989) (221)
- Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. (1996) (216)
- Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. (1990) (214)
- Epidemiology and natural history of primary biliary cirrhosis in a US community. (2000) (196)
- A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. (1990) (195)
- Quality of life before and after liver transplantation for cholestatic liver disease (1999) (193)
- Bone disease in liver transplant recipients: incidence, timing, and risk factors. (1991) (187)
- Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. (1985) (183)
- Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. (1989) (182)
- Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (2000) (181)
- Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. (1995) (179)
- Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. (1999) (179)
- Time course of histological progression in primary biliary cirrhosis (1996) (175)
- Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. (2001) (161)
- Outcome of liver transplantation for hepatitis B in the United States (2004) (157)
- Recurrence of nonalcoholic steatohepatitis following liver transplantation. (1996) (157)
- Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end‐stage liver disease (2000) (157)
- Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies (1996) (157)
- Diagnosis of Wilson's disease presenting as fulminant hepatic failure. (1983) (156)
- Trial of penicillamine in advanced primary biliary cirrhosis. (1985) (154)
- Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. (1997) (152)
- Deaths on the liver transplant waiting list: An analysis of competing risks (2006) (152)
- Cost-Effectiveness of 6 and 12 Months of Interferon- Therapy for Chronic Hepatitis C (1997) (150)
- SYSTEMIC AND RENAL HEMODYNAMIC DIFFERENCES BETWEEN FK506 AND CYCLOSPORINE IN LIVER TRANSPLANT RECIPIENTS (1993) (147)
- Antimitochondrial antibody-negative primary biliary cirrhosis. (1995) (145)
- Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis (1992) (142)
- Cost‐effectiveness of ultrasound‐guided liver biopsy (1998) (141)
- Splenosis: autotransplantation of splenic tissue. (1976) (141)
- Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: What is the risk? (1992) (140)
- Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. (1994) (136)
- Primary biliary cirrhosis: Associations with class II major histocompatibility complex antigens (1987) (136)
- Epitope mapping and reactivity of autoantibodies to the E2 component of 2‐oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2‐oxoglutarate dehydrogenase complex (1996) (136)
- Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis (1999) (133)
- IMPACT OF NUTRITIONAL STATUS ON OUTCOMES AFTER LIVER TRANSPLANTATION1 (2000) (132)
- Increased prevalence of antimitochondrial antibodies in first‐degree relatives of patients with primary biliary cirrhosis (2007) (128)
- Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. (1999) (127)
- Tumor necrosis factor‐α and transforming growth factor‐β reflect severity of liver damage in primary biliary cirrhosis (2002) (125)
- The relative role of the child‐pugh classification and the mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis (1999) (125)
- Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. (1990) (123)
- Pigmented corneal rings in non-Wilsonian liver disease. (1977) (120)
- Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross‐reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex (1989) (118)
- Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? (1995) (118)
- Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. (1993) (116)
- Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. (1995) (111)
- Predicting Survival among Patients Listed for Liver Transplantation: An Assessment of Serial MELD Measurements (2004) (111)
- Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. (2008) (110)
- Primary Sclerosing Cholangitis (1984) (110)
- Extramural cross‐validation of the mayo primary biliary cirrhosis survival model establishes its generalizability (1989) (106)
- Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched‐chain α‐keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen (1989) (106)
- Outcome of hospital care of liver disease associated with hepatitis C in the United States (2001) (104)
- Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. (1993) (103)
- Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. (1998) (102)
- The metabolic bone disease of primary sclerosing cholangitis (1991) (102)
- Copper and primary biliary cirrhosis. (1974) (101)
- Incidence of cancer in primary biliary cirrhosis: The mayo experience (1998) (99)
- A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease (1997) (97)
- The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. (1995) (94)
- Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation (1997) (93)
- Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. (1987) (90)
- Optimal timing of liver transplantation for primary biliary cirrhosis (1998) (89)
- Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: Relationship of levels of autoantibodies to disease progression (1997) (87)
- Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex. (1989) (87)
- Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. (1999) (86)
- Primary thrombocythaemia treated with busulphan (1986) (85)
- Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. (1993) (81)
- Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. (2002) (81)
- Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. (2000) (81)
- Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. (1995) (80)
- Primary biliary cirrhosis and lichen planus. (1983) (80)
- Changing Concepts in the Surgical Treatment of Gallstone Ileus: A Review of 15 Cases with Emphasis on Diagnosis and Treatment (1968) (78)
- The economic impact of cytomegalovirus infection after liver transplantation. (2000) (74)
- Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis. (1981) (73)
- Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. (1997) (73)
- Cirrhosis and death after jejunoileal shunt. (1972) (71)
- Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization (1999) (71)
- Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis. (1977) (70)
- M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena? (1992) (66)
- Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine. (1978) (65)
- Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. (1992) (65)
- Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. (1976) (65)
- Inhibition of α‐ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis (1990) (65)
- An association between HLA DR1 and lichen planus (1986) (64)
- A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. (2001) (64)
- TREATMENT OF PRURITUS OF CHOLESTASIS BY PLASMA PERFUSION THROUGH USP-CHARCOAL-COATED GLASS BEADS (1980) (63)
- Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis (1986) (63)
- Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function. (1973) (63)
- Pathogenesis of steatorrhea in primary biliary cirrhosis (1985) (61)
- Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis (1988) (56)
- Primary biliary cirrhosis. (1979) (51)
- Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates (2000) (49)
- Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. (1994) (48)
- Preciitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis. (1980) (47)
- Nutritional status of a group of alcoholics before and after admission to an alcoholism treatment unit. (1981) (45)
- ANTINUCLEAR ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS (1984) (44)
- Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. (1978) (44)
- Studies of chronic idiopathic jaundice (Dubin-Johnson syndrome). II. Evaluation of a large family with the trait. (1963) (43)
- A prospective study of pulmonary function and gas exchange following liver transplantation. (1992) (41)
- Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis. (1993) (41)
- Employment and Health Insurance in Long‐Term Liver Transplant Recipients (2005) (40)
- Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis (1998) (39)
- Abnormal expression of PDC‐E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody‐negative primary biliary cirrhosis (1995) (39)
- Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis (1995) (38)
- Primary sclerosing cholangitis. (1984) (38)
- Systemic and Renal Effects of Nifedipine in Cyclosporine‐Associated Hypertension (1994) (37)
- Results of long-term ursodiol treatment for patients with primary biliary cirrhosis (2002) (36)
- Plasmaperfusion for the treatment of intractable pruritus of cholestasis. (1978) (35)
- Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: Applications of a semiautomated assay (1994) (33)
- Lichen planus, primary biliary cirrhosis and penicillamine (1982) (33)
- Combined analysis of French, American and Canadian randomized controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis (1995) (32)
- Preoperative predictors of resource utilization in liver transplantation. (1995) (30)
- Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. (1989) (30)
- Human liver and conjugation of catecholamines. (1987) (30)
- The pharmacokinetics of D-penicillamine in man. (1981) (28)
- The association of Churg-Strauss vasculitis with temporal artery involvement, primary biliary cirrhosis, and polychondritis in a single patient. (1982) (26)
- Pigmented corneal rings in a patient with primary biliary cirrhosis. (1975) (25)
- Hepatic subcellular distribution of copper in primary biliary cirrhosis. Comparison with other hyperhepatocupric states and review of the literature. (1977) (25)
- Adjuvant Cholylsarcosine During Ursodeoxycholic Acid Treatment of Primary Biliary Cirrhosis (1998) (25)
- Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigens. (1992) (24)
- The natural history of abdominal pain associated with primary biliary cirrhosis. (1994) (24)
- Removal of bile acids and bilirubin by plasmaperfusion of U.S.P. charcoal-coated glass beads. (1979) (24)
- Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. (1999) (23)
- Copper stains and the syndrome of primary biliary cirrhosis. Evaluation of staining methods and their usefulness for diagnosis and trials of penicillamine treatment. (1979) (22)
- Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. (1996) (21)
- Primary biliary cirrhosis: Relation between hepatic function and pulmonary function in patients who never smoked (1991) (21)
- Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis. (1990) (19)
- Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis. (1976) (18)
- Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy (1998) (18)
- Cholangiographic findings in cholangiolitic hepatitis. Syndrome of primary biliary cirrhosis. (1971) (17)
- Glucose-6-phosphate dehydrogenase variants: reexamination of G6PD Chicago and Cornell and a new variant (G6PD Pea Ridge) resembling G6PD Chicago. (1980) (17)
- Chronic active hepatitis : the Mayo Clinic experience (1986) (17)
- Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. (1998) (15)
- Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload. (1978) (15)
- Is primary sclerosing cholangitis a progressive disease or not? (1988) (15)
- The autologous mixed lymphocyte reaction in primary biliary cirrhosis: Analysis of activation and blastogenesis of autoreactive T lymphocytes (1988) (15)
- Hepatoportal arteriovenous fistula: morphologic features studied after orthotopic liver transplantation. (1989) (15)
- d-Penicillamine in primary biliary cirrhosis: apparent beneficial effects in spite of a lack of correlation with changes in hepatic copper concentrations (1978) (14)
- The relative affinity of recombinant dihydrolipoamide transacetylase for autoantibodies in primary biliary cirrhosis (1990) (12)
- Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients. (1987) (12)
- Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantation. (1997) (11)
- D-penicillamine improves survival and retards histologic progression in primary biliary cirrhosis (1982) (10)
- Prediction of liver transplant outcome using the MELD scale (2001) (10)
- Rupture of abdominal aortic aneurysm into vena cava. Electrocardiographic changes. (1963) (9)
- Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features. (1982) (9)
- ULTRASTRUCTURAL CHANGES OF THE LIVER IN BENIGN RECURRENT CHOLESTASIS. (1965) (9)
- Plasmaperfusion and studies of copper metabolism in benign recurrent cholestasis: novel procedures in a rare syndrome. (1980) (8)
- Primary biliary cirrhosis clinical research single‐topic conference (1996) (8)
- Pharmacokinetics of D-penicillamine in normals and primary biliary cirrhosis (PBC) (1979) (7)
- Predictive models of natural history in primary biliary cirrhosis. (1998) (7)
- Lichen planus and the liver (1991) (6)
- Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy (1995) (6)
- 759 Outcome of liver transplantation for hepatitis B in the U.S. (2003) (6)
- The composition of the isolated soluble immune complexes in primary biliary cirrhosis (PBC) (1978) (5)
- Economic analysis of interferon/ribavirin treatment in patients with chronic hepatitis C who relapse following initial interferon therapy (1998) (5)
- The timing of liver transplantation in primary biliary cirrhosis. (2000) (5)
- Comparative metabolism and structure of BCKD-E2 in primary biliary cirrhosis. (1993) (5)
- Hereditary sideroblastic anemia. (1991) (4)
- Timing of liver transplantation. (2000) (4)
- Chronic active liver disease with common variable hypogammaglobulinemia. (1979) (4)
- 25 – NUTRITIONAL STATUS OF ALCOHOLICS BEFORE AND AFTER ADMISSION TO AN ALCOHOLISM TREATMENT UNIT (1979) (4)
- The role of prognostic models in the timing of liver transplantation. Application in cholestatic liver diseases. (1997) (3)
- The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis (1998) (3)
- Survival algorithms and outcome analysis in primary biliary cirrhosis. (1997) (3)
- Antemortem diagnosis and short-term survival of a patient with Wilson's disease presenting as fulminant hepatic failure (1984) (3)
- Methotrexate in the treatment of primary biliary cirrhosis: the hype and the hope. (1999) (3)
- Depletion of Bile Acids and Bilirubin in Dogs with Biliary Obstruction by Plasmaperfusion of Usp-Charcoal-Coated Glass Beads (1980) (3)
- Liver transplantation for primary biliary cirrhosis (1992) (2)
- Is routine cholangiography useful in men with suspected primary biliary cirrhosis? (1999) (2)
- Gallium accumulation in the stomach: a false-positive scan suggesting abscess. (1979) (2)
- The syndrome of primary biliary cirrhosis. (1981) (2)
- Intrahepatic Distribution of Tritiated Bilirubin in Normal and Gunn Rats (1967) (2)
- Prognosis in PBC: Who should we believe? (1990) (1)
- Hormone replacement therapy is safe and effective in decreasing bone loss in postmenopausal patients with primary biliary cirrhosis (2000) (1)
- Tune course of histological progression in primary biliary cirrhosis (1996) (1)
- Long-term ursodeoxycholic acid therapy delays histologic progression in primary biliary cirrhosis (1998) (1)
- Reply (2001) (0)
- Prevalence of celiac disease in a north american population with primary biliary cirrhosis - is screening worthwhile? (2000) (0)
- Sa1027 Plasma Cysteine Levels and Muscle Cramps in Patients With Cirrhosis (2012) (0)
- The pharmacokinetics of D-penicillamine in health and primary biliary cirrhosis (PBC) (1980) (0)
- Natural history models of primary biliary cirrhosis (1998) (0)
- Cholestatic liver disease: an overview. (1998) (0)
- Letter: Polymyalgia rheumatica and liver disease. (1974) (0)
- 540 Estimation of glomerular filtration rate in patients with end-stage liver disease: a new model superior to Cockroft-Gault (2003) (0)
- Hepatopulmonary Syndrome* ClinicalObservations andLackof Therapeutic ResponseToSomatostatin Analogue (2017) (0)
- 12 PROGNOSTIC VALUE OF SERUM SODIUM CONCENTRATION AND MODEL FOR END-STAGE LIVER DISEASE IN PATIENTS ON THE LIVER TRANSPLANTATION WAITING LIST (2005) (0)
- ADAPTATION OF THE MAYO PRIMARY BILIARY CIRRHOSIS MODEL FOR MINIMUM LISTING CRITERIA FOR LIVER TRANSPLANT CANDIDATES (1998) (0)
- Mortality and expenditure related to hepatitis C in the US (2000) (0)
- intheImpairment ofOsteoblast Proliferation Associated withCholestatic Jaundice (1995) (0)
- Reply of the authors: Determination of Copper in Needle Biopsies of the Liver (1975) (0)
- LOWER QUALITY OF LIFE IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C.: Abstract# 398 Poster Board #‐Session: P38‐II (2000) (0)
- DETERMINANTS OF OUTCOME OF LIVER TRANSPLANTATION IN US, 1988‐1996.: Abstract# 987 (2000) (0)
- Silymarin for patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid (2000) (0)
- POLYMYALGIA RHEUMATICA AND LIVER DISEASE (1974) (0)
- The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study (1995) (0)
- Short-term ursodeoxycholic acid therapy delays stage progression in patients with primary biliary cirrhosis (2000) (0)
- Asymptomatic primary biliary cirrhosis: Presentation, histology, and short-term course in d-penicillamine trial (1978) (0)
- Characterisation ofpatients withacomplete biochemical responsetoursodeoxycholic acid (2011) (0)
- Nutritional assessment parameters in patients awaiting liver transplantation: Correlation with body cell mass (1998) (0)
- Alpha1 low density lipoprotein: A marker for primary biliary cirrhosis (1978) (0)
This paper list is powered by the following services: